Table 3.
Maximum Correlations of the Average Head and Neck Lymphedema and Fibrosis Symptom Inventory Scores with Established Self-Report Measure Scores
| Established measures | HN-LEF Symptom Inventory |
||||||
|---|---|---|---|---|---|---|---|
| Soft issues/neurologic toxicity | Systemic symptoms/social functioning | Jaw and oral dysfunction | Swallowing and taste changes | Body image and sexuality | Communication | Mucosal irritation | |
| EORTC-QLQ Global Health | −0.47 | −0.58 | −0.45 | −0.41 | −0.34 | −0.44 | −0.48 |
| Neck Disability Index | 0.57 | 0.72 | 0.48 | 0.39 | 0.47 | 0.49 | 0.49 |
| Short-Form McGill Pain Questionnaire | |||||||
| Sensory | 0.52 | 0.53 | 0.53 | 0.53 | 0.44 | 0.52 | 0.50 |
| Affective | 0.50 | 0.64 | 0.43 | 0.54 | 0.49 | 0.49 | 0.54 |
| Present pain intensity | 0.54 | 0.56 | 0.50 | 0.47 | 0.31 | 0.43 | 0.42 |
| Visual analogue | 0.56 | 0.63 | 0.38 | 0.49 | 0.34 | 0.44 | 0.44 |
| VHNSS | |||||||
| Mouth pain | 0.32 | 0.44 | 0.30 | 0.60 | 0.45 | 0.29 | 0.39 |
| General pain | 0.56 | 0.56 | 0.45 | 0.52 | 0.34 | 0.49 | 0.58 |
| Swallowing solids | 0.23 | 0.45 | 0.46 | 0.61 | 0.43 | 0.40 | 0.47 |
| Swallowing liquids | 0.16 | 0.37 | 0.19 | 0.44 | 0.31 | 0.34 | 0.50 |
| Nutrition | 0.16 | 0.52 | 0.33 | 0.61 | 0.37 | 0.24 | 0.47 |
| Mucus | 0.38 | 0.49 | 0.36 | 0.51 | 0.36 | 0.45 | 0.60 |
| Dry mouth | 0.24 | 0.59 | 0.19 | 0.70 | 0.40 | 0.34 | 0.41 |
| Taste/smell | 0.24 | 0.45 | 0.27 | 0.64 | 0.48 | 0.26 | 0.36 |
| Voice/communication | 0.51 | 0.56 | 0.53 | 0.53 | 0.58 | 0.76 | 0.62 |
| Teeth | 0.40 | 0.27 | 0.38 | 0.32 | 0.45 | 0.32 | 0.25 |
| Hearing | 0.31 | 0.48 | 0.44 | 0.33 | 0.24 | 0.40 | 0.52 |
| Trismus | 0.41 | 0.32 | 0.70 | 0.37 | 0.36 | 0.41 | 0.28 |
| Neck range of motion | 0.57 | 0.36 | 0.45 | 0.37 | 0.50 | 0.48 | 0.26 |
| Hospital Anxiety and Depression Scale | |||||||
| Total | 0.46 | 0.73 | 0.42 | 0.45 | 0.56 | 0.54 | 0.54 |
| Anxiety | 0.37 | 0.64 | 0.34 | 0.32 | 0.46 | 0.43 | 0.49 |
| Depression | 0.53 | 0.71 | 0.46 | 0.53 | 0.54 | 0.59 | 0.51 |
| VHNSS-GSS | |||||||
| Unexplained fatigue | 0.47 | 0.71 | 0.37 | 0.44 | 0.37 | 0.50 | 0.53 |
| Fatigue limits activity | 0.42 | 0.71 | 0.37 | 0.51 | 0.37 | 0.50 | 0.57 |
| Falling asleep | 0.49 | 0.64 | 0.43 | 0.43 | 0.29 | 0.26 | 0.45 |
| Staying asleep | 0.42 | 0.66 | 0.30 | 0.45 | 0.39 | 0.33 | 0.49 |
| Unexplained sweating | 0.42 | 0.47 | 0.28 | 0.19 | 0.25 | 0.41 | 0.49 |
| Cold | 0.27 | 0.51 | 0.23 | 0.55 | 0.33 | 0.33 | 0.35 |
| Hot | 0.22 | 0.46 | 0.30 | 0.30 | 0.28 | 0.32 | 0.37 |
| Memory | 0.47 | 0.41 | 0.35 | 0.34 | 0.31 | 0.48 | 0.37 |
| Joint pain/aches | 0.46 | 0.48 | 0.36 | 0.35 | 0.29 | 0.43 | 0.45 |
| Sad/depressed | 0.31 | 0.57 | 0.31 | 0.43 | 0.48 | 0.40 | 0.41 |
| Anxious | 0.27 | 0.51 | 0.40 | 0.34 | 0.40 | 0.35 | 0.45 |
| Marlowe–Crowne Social Desirability Scale—Short Form C | −0.28 | −0.32 | −0.14 | −0.20 | −0.38 | −0.19 | −0.25 |
Values in italics indicate at least 20% shared variability; values in bold indicate at least 30% shared variance.
Maximum observed correlation from the posttreatment assessment time points.
Average of all symptom (item) values comprising each HN-LEF Symptom Inventory subscale.
EORTC-QLQ, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire; HN-LEF, Head and Neck Lymphedema and Fibrosis; VHNSS-GSS, Vanderbilt Head and Neck Symptom Survey—General Symptom Survey.